Tnkase 50 MG kits
Ended Awarded
- Contract number
- SPE2D325F277T
- Awardee
-
Genentech Usa, Inc. UEI SA85BMHCTXK5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,110
Award facts
- Contract value 100% obligated
- $16,109.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Department's Medical Supply Chain has awarded a delivery order to Genentech USA, Inc. for TNKase 50 mg kits, valued at $16,109.55. The contract, issued on July 30, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance will take place at Genentech's headquarters in South San Francisco, California. TNKase (tenecteplase) is a thrombolytic medication used in acute myocardial infarction treatment, critical to the federal medical supply chain for emergency preparedness and defense-related healthcare operations.
This delivery order is issued under Genentech's broader $27.9 million indefinite delivery contract with Defense Logistics Agency Troop Support Medical, which runs through May 2031 and enables flexible procurement of medical supplies with pre-established pricing. As a foreign-owned biotechnology manufacturer registered in SAM.gov since 2008, Genentech has established itself as a reliable supplier of specialized pharmaceuticals to federal agencies including the Department of Veterans Affairs, the Office of the Assistant Secretary for Preparedness and Response, and the Federal Bureau of Investigation. The company maintains an extensive portfolio of federal contract vehicles, including a substantial $4.9 billion Federal Supply Schedule agreement with the VA for drugs and pharmaceuticals, positioning it as a key provider within the federal medical supply infrastructure.
Quick answers
Who was awarded contract SPE2D325F277T?
SPE2D325F277T was awarded to Genentech Usa, Inc. by Medical Supply Chain (Troop Support) on July 30, 2025.
How much is contract SPE2D325F277T worth?
The government has obligated $16,110 on SPE2D325F277T.
Is contract SPE2D325F277T an order under another contract?
Yes. SPE2D325F277T is a delivery order under SPE2D021D0005, an indefinite delivery contract.
Was contract SPE2D325F277T competed?
The extent of competition for SPE2D325F277T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award